Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 262 to 311 of 12912 in total 
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Value Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.077\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25807\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
63.8686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
47.2654\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35128\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.075\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25805\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.074\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25804\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.144\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25802\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54716\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.144\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
336.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25802\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54715\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54711\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
129762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.68808\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
110342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
184298\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.67024\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1920.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2907.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5137\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
76\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27.9136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.2872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
110342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
184298\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.67024\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4599.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3058.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.50373\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
110342\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
184298\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.67024\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
39.9725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
52.9973\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.32584\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4612.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3093.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.49095\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.692\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2567\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
117858\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
70570.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.67008\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4800.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7132.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48573\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
63.7477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
48.1589\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3237\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/